Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$29.91 - $38.73 $5.36 Million - $6.94 Million
-179,135 Reduced 95.64%
8,165 $245,000
Q1 2023

May 01, 2023

SELL
$34.93 - $42.03 $3.07 Million - $3.7 Million
-87,955 Reduced 31.95%
187,300 $6.79 Million
Q4 2022

Feb 06, 2023

SELL
$31.09 - $37.88 $1.55 Million - $1.89 Million
-49,830 Reduced 15.33%
275,255 $9.82 Million
Q3 2022

Nov 08, 2022

BUY
$28.79 - $35.41 $9.36 Million - $11.5 Million
325,085 New
325,085 $11 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.06B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Mesirow Institutional Investment Management, Inc. Portfolio

Follow Mesirow Institutional Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Institutional Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Institutional Investment Management, Inc. with notifications on news.